Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 388

1.

Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.

Caro-Oleas JL, González-Escribano MF, Gentil-Govantes MÁ, Acevedo MJ, González-Roncero FM, Blanco GB, Núñez-Roldán A.

Transplantation. 2012 Aug 27;94(4):338-44. doi: 10.1097/TP.0b013e31825ace2c.

PMID:
22814330
2.

Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.

Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.

Nephrol Dial Transplant. 2012 Mar;27(3):1231-8. doi: 10.1093/ndt/gfr429. Epub 2011 Aug 2.

3.
4.

Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.

Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.

Transplantation. 2013 Jan 27;95(2):341-6. doi: 10.1097/TP.0b013e3182743cfa.

PMID:
23197178
5.

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.

Transplantation. 2013 Jan 15;95(1):19-47. doi: 10.1097/TP.0b013e31827a19cc.

PMID:
23238534
6.

Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.

Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.

Hum Immunol. 2009 Aug;70(8):589-94. doi: 10.1016/j.humimm.2009.04.018. Epub 2009 Apr 15.

PMID:
19375470
7.

Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?

Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.

Transpl Immunol. 2013 Dec;29(1-4):28-33. doi: 10.1016/j.trim.2013.07.002. Epub 2013 Jul 29.

PMID:
23907088
8.

Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.

Lefaucheur C, Suberbielle-Boissel C, Hill GS, Nochy D, Andrade J, Antoine C, Gautreau C, Charron D, Glotz D.

Contrib Nephrol. 2009;162:1-12. doi: 10.1159/000170788. Epub 2008 Oct 31.

PMID:
19001809
9.

Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.

Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.

Transpl Immunol. 2015 Mar;32(2):66-71. doi: 10.1016/j.trim.2015.01.002. Epub 2015 Feb 7.

PMID:
25661873
10.

Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.

Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.

Clin Biochem. 2013 Oct;46(15):1389-93. doi: 10.1016/j.clinbiochem.2013.05.053. Epub 2013 May 29.

PMID:
23726814
11.
12.

Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.

Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D.

Transplantation. 2011 Oct 27;92(8):900-6. doi: 10.1097/TP.0b013e31822dc38d.

PMID:
21968524
13.

Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.

Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S.

Transplantation. 2009 Jun 15;87(11):1681-8. doi: 10.1097/TP.0b013e3181a5e034.

PMID:
19502960
14.

Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.

Thammanichanond D, Ingsathit A, Mongkolsuk T, Rattanasiri S, Kantachuvesiri S, Sakhonrat C, Leenanupan C, Worawichawongs S, Kitpoka P.

Asian Pac J Allergy Immunol. 2012 Mar;30(1):48-54.

15.

Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation.

Riethmüller S, Ferrari-Lacraz S, Müller MK, Raptis DA, Hadaya K, Rüsi B, Laube G, Schneiter G, Fehr T, Villard J.

Transplantation. 2010 Jul 27;90(2):160-7.

PMID:
20658760
16.

Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.

Ginevri F, Nocera A, Comoli P, Innocente A, Cioni M, Parodi A, Fontana I, Magnasco A, Nocco A, Tagliamacco A, Sementa A, Ceriolo P, Ghio L, Zecca M, Cardillo M, Garibotto G, Ghiggeri GM, Poli F.

Am J Transplant. 2012 Dec;12(12):3355-62. doi: 10.1111/j.1600-6143.2012.04251.x. Epub 2012 Sep 7.

17.

Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.

Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.

Transplantation. 2014 Mar 27;97(6):642-7. doi: 10.1097/01.TP.0000440954.14510.6a.

PMID:
24637863
18.

Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.

Kayler LK, Farber JL, Colombe B, LaCava D, Friedewald JJ, Ratner LE.

Transpl Int. 2006 Feb;19(2):128-39.

19.

Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.

Hirai T, Kohei N, Omoto K, Ishida H, Tanabe K.

Transpl Int. 2012 Sep;25(9):925-34. doi: 10.1111/j.1432-2277.2012.01518.x. Epub 2012 Jul 6.

20.

De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.

Seveso M, Bosio E, Ancona E, Cozzi E.

Contrib Nephrol. 2009;162:87-98. doi: 10.1159/000170841. Epub 2008 Oct 31. Review.

PMID:
19001816
Items per page

Supplemental Content

Write to the Help Desk